Join Repare Therapeutics’ management team in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami. Check out our webcast to hear the latest updates: https://lnkd.in/eKbrQQfq #syntheticlethality #clinicaltrials $RPTX
Repare Therapeutics’ Post
More Relevant Posts
-
Thanks to everyone who joined today's panel on External Innovation at Longwood Healthcare Leaders Conference! It was an honor joining this distinguished group of healthcare experts to talk about a topic with great potential to impact the world of biopharma. See how H1 is innovating to connect the world to the right doctors here: https://hubs.la/Q022Mzcs0
To view or add a comment, sign in
-
-
On November 16, 2023, an important event on "Partnering and Business Models in Precision Medicine" will be presented by Johnson & Johnson Innovation’s Science & Partnering Forum. Why does precision medicine matter? 🔍 Discover how it can revolutionize healthcare by eliminating trial-and-error practices, saving costs, and improving patient lives. Some key speakers worth mentioning: - Gabriele Alegri, Head Global Commercial Strategy Precision Medicine, Johnson & Johnson - Elena Fernandez Kleinlein Fernandez-Kleinlein, Head of JLABS EMEA, Johnson & Johnson Innovation - Dianne Baunbaek, Diagnostics Lead, Johnson & Johnson ...and many more! ✨ Curious? Full agenda & panel details here: https://buff.ly/46qLDe1 Don't miss this opportunity to gain insights into the future of precision medicine. Register now and be part of the conversation. #PrecisionMedicine #Innovation #Healthcare #JNJInnovation #UtrechtInc #Johnson&Johnson
To view or add a comment, sign in
-
-
From SF Standard: The 42nd annual J.P. Morgan Healthcare Conference has drawn thousands, including former British Prime Minister Tony Blair and JPMorgan Chase & Co. CEO Jamie Dimon, to Union Square’s Westin St. Francis. The event, a significant boost for downtown businesses, is expected to attract over 8,000 attendees and has already seen over $6.4 billion in healthcare deals announced, with a focus on artificial intelligence and presentations from industry giants like Pfizer, Moderna, and Merck. Last year's in-person conference generated around $86 million in economic impact for San Francisco, marking a return to in-person events after COVID disruptions. https://lnkd.in/gtQr6G7C
To view or add a comment, sign in
-
In a recent KPMG survey of deal-maker preference across healthcare and life sciences, late-stage assets garnered 70% of the vote, versus 55% for early-stage, highly innovative assets and 45% for agents at the commercial stage. Read more in Medical Marketing and Media:
To view or add a comment, sign in
-
In a recent KPMG survey of deal-maker preference across healthcare and life sciences, late-stage assets garnered 70% of the vote, versus 55% for early-stage, highly innovative assets and 45% for agents at the commercial stage. Read more in Medical Marketing and Media:
How biotech companies are standing out during JPM Week
To view or add a comment, sign in
-
In a recent KPMG survey of deal-maker preference across healthcare and life sciences, late-stage assets garnered 70% of the vote, versus 55% for early-stage, highly innovative assets and 45% for agents at the commercial stage. Read more in Medical Marketing and Media:
How biotech companies are standing out during JPM Week
kpmg.voicestorm.com
To view or add a comment, sign in
-
"Value creation is a term that is frequently used but often misunderstood. In healthcare, we believe true value creation goes beyond financial success and also creates a positive impact on the patients, medical community and overall society. At CBC Group, we seek to widen access to affordable medical healthcare, catalyze innovations globally, and fulfill unmet medical needs," said Billy Cho, Senior Managing Director, Private Equity and Head of Joint Value Creation of CBC Group, during a panel discussion at the 2024 Private Equity Asia Forum organized by Markets Group. Titled "Portfolio Optimization & Value Creation – Tools & Strategies Leading Funds use to Support Growth & Reduce Costs", Billy and his fellow panelists discussed strategies to increase productivity while launching new products and entering new markets, highlighting the various tactics GPs are utilizing to preserve liquidity, drive earnings growth, and most importantly – create long term value! #CBCGroup #PrivateEquity #ValueCreation #InvestorOperator #Healthcare #Investments #MarketsGroupPE
To view or add a comment, sign in
-
-
In advance of our 2023 Global Healthcare Conference in London, we sat down with the leaders of our Healthcare Investment Banking and Healthcare Equity Research teams to hear what they had to say about the opportunities and challenges they see in the market. They discuss everything from their cautious optimism about the markets to funding challenges to a bounce back for M&A, and even weigh-in on the emergence and outlook of weight-loss drugs. See some of what they had to say below and access their full interviews, plus the results of the 6th edition of the Jefferies Healthcare Temperature Check, here: https://lnkd.in/gvNzxQEW These, and many other topics, will be on the agenda during our three-day Healthcare Conference in Europe. We're expecting a record attendance of over 3,000 participants representing nearly 700 healthcare corporates, private equity and venture capital firms, institutional investors, and other leaders from the healthcare sector. #JefferiesHealthcare
To view or add a comment, sign in
-
Vice President, Public Affairs at Kyowa Kirin, Inc. | Head, Corporate Communications and Patient Advocacy | KKNA Executive Committee
Still soaking up the last moments of summer, but it’s time to mark our calendars for the Pharma & Patient USA meeting this fall! Let's come together to discuss how we elevate patient voices and advance patient interests through stronger #patientadvocacy engagements and cross-functional partnerships. See you there! #teamwork #profoundimpact #makingpeoplesmile
To view or add a comment, sign in
-
-
Great to be at #cmosummit360 in Boston and to hear Gary Pisano’s keynote this morning. So many great points, not least the challenge of bringing together two such different worlds; Business and Science. I think that there’s a third arm to this challenge - doing it in such a way that fits best with the day to day needs of those who ultimately receive the medicine - patients. The science and the business model needs to deliver the difference that patients actually want and value, as this is the real win/win and will ultimately increase the asset value hugely. #patientfocus #biopharma #assetvalue #patientinsights #patientengagement Origins - The Patient Focused Specialists RESONANT GROUP
To view or add a comment, sign in
-